$0.8800
-0.06-6.88%
At close: -
$1.35
0.4753.41%
After Hours: Mar 26, 9:03 AM EDT
Comments
Loading...
Eagle Pharmaceuticals Stock Guidance | OTC:EGRX | Benzinga
Eagle Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/07/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.40 | $4.70 | $4.58 | — | — | — | Get Alert |
| 08/17/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.40 | $4.70 | $4.47 | — | — | — | Get Alert |
| 08/08/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.40 | $4.70 | $4.34 | — | — | — | Get Alert |
| 07/31/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.40 | $4.70 | $4.26 | — | — | — | Get Alert |
| 06/15/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.20 | $4.53 | $4.29 | — | — | — | Get Alert |
| 05/09/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.20 | $4.53 | $4.21 | — | — | — | Get Alert |
| 03/13/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.20 | $4.53 | $4.49 | — | — | — | Get Alert |
| 01/10/2023 | EGRX | Eagle Pharmaceuticals | FY | 2022 | $7.54 | $7.54 | $7.58 | — | — | — | Get Alert |
| 01/10/2023 | EGRX | Eagle Pharmaceuticals | FY | 2023 | $4.20 | $4.53 | $4.42 | — | — | — | Get Alert |
| 03/07/2022 | EGRX | Eagle Pharmaceuticals | Q1 | 2022 | $3.80 | $4.10 | — | $120.00M | $130.00M | — | Get Alert |
FAQ
What is the most recent guidance for Eagle Pharmaceuticals (EGRX)?
The most recent guidance for Eagle Pharmaceuticals (EGRX) was reported on September 7, 2023 for the full year 2023. The company provided earnings per share guidance in the range of $4.40 to $4.70, compared to the estimated EPS of $4.58. Additionally, Eagle Pharmaceuticals forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.